Evidence map›Paper›PMID 34305908›Full record

ArticleFrontiers in immunology2021

Dectin-1 Controls TSLP-Induced Th2 Response by Regulating STAT3, STAT6, and p50-RelB Activities in Dendritic Cells.

Chao Gu, Katherine Upchurch, Joshua Horton, Mathew Wiest, Sandra Zurawski, Mark Millard, Robert R Kane, HyeMee Joo, Lisa A Miller, SangKon Oh

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. The role of the CBM complex in allergic inflammation and disease.The Journal of allergy and clinical immunology · 2022
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Chao GuDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, United States.
Katherine UpchurchInstitute of Biomedical Studies, Baylor University, Waco, TX, United States.
Joshua HortonInstitute of Biomedical Studies, Baylor University, Waco, TX, United States.
Mathew WiestDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, United States.
Sandra ZurawskiBaylor Research Institute, Dallas, TX, United States.
Mark MillardDepartment of Pulmonology, Baylor University Medical Center, Dallas, TX, United States.
Robert R KaneInstitute of Biomedical Studies, Baylor University, Waco, TX, United States.
HyeMee JooDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, United States.
Lisa A MillerCalifornia National Primate Research Center, University of California, Davis, Davis, CA, United States.
SangKon OhDepartment of Immunology, Mayo Clinic, Scottsdale, AZ, United States.
Baylor University · USMayo Clinic in Arizona · USBaylor University Medical Center · USUniversity of California, Davis · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Controlling Allergen-specific Th2-type Responses by Targeting DC Surface LectinsR21AI101810 · NIAID · BAYLOR RESEARCH INSTITUTE · PI OH, SANGKON · 2012 to 2013
$429k
NIAID NIH HHS R21 AI101810
6 · The paper itself

Abstract

The epithelium-associated cytokine thymic stromal lymphopoietin (TSLP) can induce OX40L and CCL17 expression by myeloid dendritic cells (mDCs), which contributes to aberrant Th2-type immune responses. Herein, we report that such TSLP-induced Th2-type immune response can be effectively controlled by Dectin-1, a C-type lectin receptor expressed by mDCs. Dectin-1 stimulation induced STAT3 activation and decreased the transcriptional activity of p50-RelB, both of which resulted in reduced OX40L expression on TSLP-activated mDCs. Dectin-1 stimulation also suppressed TSLP-induced STAT6 activation, resulting in decreased expression of the Th2 chemoattractant CCL17. We further demonstrated that Dectin-1 activation was capable of suppressing ragweed allergen (Amb a 1)-specific Th2-type T cell response in allergy patients

Indexed as

AdultAllergensAnimalsAntigens, DermatophagoidesAntigens, Plantbeta-GlucansCase-Control StudiesCytokinesDectin-1Dendritic CellsDermatophagoides farinaeDisease Models, AnimalFemaleHEK293 CellsHumansHypersensitivityAllergensAmb a I protein, Ambrosia artemisiifoliaAntigens, DermatophagoidesAntigens, Plantbeta-GlucansCLEC7A protein, humancurdlanCytokinesDectin-1Lectins, C-TypeNF-kappa B p50 SubunitOX40 LigandPlant ProteinsRELB protein, humanSTAT3 protein, humanSTAT3 Transcription FactorSTAT6 protein, humanSTAT6 Transcription FactorThymic Stromal LymphopoietinTNFSF4 protein, humanTranscription Factor RelBallergyDectin-1dendritic cellsOX40LSTAT3STAT6Th2 cellsTSLP

Identifiers

PMID34305908
PMCPMC8293820
OpenAlexW3177932190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.